ADIPOQ and breast cancer: In another meta-analysis study published in 2017 [58] including 119 studies with 12,301 breast cancer cases and 12,805 controls, Yu Gui et al. found that decreased circulating adiponectin levels and increased concentrations of leptin were significantly associated with increased breast cancer risk.